Group One Trading
CPRX

Group One Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Group One Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Buy
+1,909
New +$56.3K ﹤0.01% 5258
2024
Q4 		– Sell
-8,108
Closed -$174K – 7367
2024
Q3 		$161K Sell
8,108
-7,559
-48% -$140K ﹤0.01% 3811
2024
Q2 		$243K Buy
15,667
+4,657
+42% +$72.5K ﹤0.01% 3240
2024
Q1 		$175K Buy
+11,010
New +$166K ﹤0.01% 3674
2022
Q2 		– Sell
-9,242
Closed -$67.8K – 7909
2022
Q1 		$77K Buy
9,242
+3,689
+66% +$26.1K ﹤0.01% 5745
2021
Q4 		$38K Sell
5,553
-21,503
-79% -$141K ﹤0.01% 6526
2021
Q3 		$143K Sell
27,056
-78,192
-74% -$428K ﹤0.01% 5524
2021
Q2 		$605K Buy
+105,248
New +$543K ﹤0.01% 4007
2020
Q2 		– Sell
-201,698
Closed -$906K – 5829
2020
Q1 		$777K Buy
201,698
+37,795
+23% +$155K 0.01% 1723
2019
Q4 		$615K Sell
163,903
-22,895
-12% -$107K ﹤0.01% 2267
2019
Q3 		$992K Buy
186,798
+149,586
+402% +$797K 0.01% 1745
2019
Q2 		$143K Buy
+37,212
New +$161K ﹤0.01% 3086
2019
Q1 		– Sell
-16,764
Closed -$49.3K – 4878
2018
Q4 		$32K Buy
16,764
+2,458
+17% +$7.04K ﹤0.01% 3773
2018
Q3 		$54K Buy
14,306
+2,082
+17% +$6.52K ﹤0.01% 3930
2018
Q2 		$38K Buy
12,224
+10,239
+516% +$31.1K ﹤0.01% 4089
2018
Q1 		$5K Buy
1,985
+411
+26% +$1.37K ﹤0.01% 4496
2017
Q4 		$6K Sell
1,574
-979
-38% -$3.23K ﹤0.01% 4507
2017
Q3 		$6K Buy
+2,553
New +$7K ﹤0.01% 4425
2015
Q4 		– Sell
-1,398
Closed -$4K – 4784
2015
Q3 		$4K Buy
+1,398
New +$6.03K ﹤0.01% 4539
2014
Q3 		– Sell
-26,248
Closed -$68.6K – 5167
2014
Q2 		$66K Buy
26,248
+13,572
+107% +$29K ﹤0.01% 3345
2014
Q1 		$29K Sell
12,676
-224
-2% -$468 ﹤0.01% 3999
2013
Q4 		$25K Buy
+12,900
New +$26.1K ﹤0.01% 4120

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's CPRX Position: Q2 2026 in Review

Group One Trading opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 1,909 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #5258 among its holdings. This is a return to the name: Group One Trading previously reported a position in CPRX as recently as Q3 2024.

Group One Trading first reported a position in CPRX in Q4 2013 and has held it in 22 quarters since. The position peaked at $992K in Q3 2019. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Group One Trading held 1,909 shares of Catalyst Pharmaceutical worth $60K as of Q2 2026.
  • Catalyst Pharmaceutical was a new Group One Trading position in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5258 holding.
  • Group One Trading first reported a position in Catalyst Pharmaceutical in Q4 2013 and has held it in 22 quarters since.
  • Group One Trading's Catalyst Pharmaceutical position peaked at $992K in Q3 2019.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.